
Elizabeth Holmes moved ahead with Walgreens rollout despite internal concerns, former Theranos scientist testifies
CNN
A longtime Theranos scientist depicted Elizabeth Holmes as prioritizing a business partnership over the possible well-being of patients in testimony capping off the first full week of witnesses taking the stand in the criminal trial of the disgraced founder.
The witness, Surekha Gangakhedkar, a scientist who worked for Theranos for eight years before quitting over her concerns about the company's capabilities, will continue her testimony Tuesday when the high-profile trial resumes in a San Jose federal courtroom.
Gangakhedkar testified Friday that Holmes was directly knowledgeable about the failings of its proprietary blood analyzer machine yet moved forward with the rollout of its devices to Walgreens locations.

5 things to know for July 16: Epstein files, DOGE cuts, National Guard, DoD contracts, All-Star Game
CNN’s 5 Things AM brings you the news you need to know every morning.

Federal investigators normally tasked with uncovering narcotic and financial crimes were told to prioritize the arrest of a university student with no criminal record, and not tell her that her visa was revoked, a Homeland Security Investigation agent testified Tuesday, a marked shift for the agency under President Donald Trump.